Dynavax Technologies Corporation Company Profile & Data: stocks, market cap, financials, digital and more

                        
Company
Dynavax Technologies CorporationHeadquarters: EmeryVille, 
                        CA, United States
                    
Employees: 311
CEO: Mr. Ryan  Spencer

                                    NASDAQ: DVAX
                                
                                            -5.19%
                                            
Market Cap$1.67 Billion

                        USD as of Jan. 1, 2025
                    
                            Market Cap History

Dynavax Technologies Corporation Categories

United States Healthcare Biotechnology
United States Healthcare United States Biotechnology

Dynavax Technologies Corporation market capitalization over time

Evolution of Dynavax Technologies Corporation market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Dynavax Technologies Corporation

Top Competitors by Market Capitalization

Industry: Biotechnology

Company	Market Cap (USD)
Novo Nordisk	$622.07 B
Vertex Pharmaceuticals Incorporated	$113.24 B
CSL Limited	$95.75 B
Regeneron Pharmaceuticals, Inc.	$76.33 B
Marinomed Biotech AG	$56.13 B

Sector:

Company	Market Cap (USD)
Lilly	$689.42 B
Novo Nordisk	$622.07 B
UnitedHealth Group	$487.54 B
Johnson & Johnson	$353.05 B
AbbVie	$301.60 B

Detailed Description

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

Top 1-year algo backtest: +327.04%

$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Financials

Last Financial Reports Date	Sept. 30, 2024
Revenue TTM	$260.8 M
EBITDA	$21.0 M
Gross Profit TTM	$161.9 M
Profit Margin	7.85%
Operating Margin	15.24%
Quarterly Revenue Growth	16.00%